[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Biopharma_Watch BiopharmaWatch
BiopharmaWatch posts on X about ticker, $cutr, $me, $repl the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +34%
- X Month XXXXXX +50%
- X Months XXXXXX -XX%
- X Year XXXXXXX +276%
Mentions: XX #
Followers: XXX #
- X Week XXX +1.50%
- X Month XXX +9.30%
- X Months XXX +47%
- X Year XXX +79%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks cryptocurrencies exchanges technology brands
Social topic influence ticker, $cutr, $me, $repl, $ocea, $wba, $imab, $phge, avg, alzheimers
Top assets mentioned Magic Eden (ME) Walgreens Boots Alliance Inc (WBA) GLOBUS MEDICAL INC (GMED) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Regeneron Pharmaceuticals Inc (REGN) Bruker, Corp. (BRKR) apM Coin (APM) Alkermes Inc. plc (ALKS) Crinetics Pharmaceuticals, Inc. (CRNX) IDEAYA Biosciences, Inc. Common Stock (IDYA) Pfizer, Inc. (PFE)
Top Social Posts #
Top posts by engagements in the last XX hours
"Highest Volume Ticker - Price - Volume $OCEA - 0.02$ - 171.4M $ZVSA - 0.65$ - 61.0M $TOVX - 0.75$ - 44.3M $ME - 0.61$ - 29.7M $CUTR - 0.10$ - 29.5M"
@Biopharma_Watch on X 2025-05-07 15:45:04 UTC XXX followers, XXX engagements
"Latest catalysts: $IMAB Catalyst Date - 2025-07-08 Drug - Givastomig (TJ033721 / ABL111) Treatment - Claudin 18.2-positive gastric cancers" @Biopharma_Watch on X 2025-07-07 15:45:04 UTC XXX followers, XXX engagements
"$AMLX 8.20$ XXXX% July XX 2025 Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase X and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025" @Biopharma_Watch on X 2025-07-14 15:45:12 UTC XXX followers, XXX engagements
"Latest catalysts: $IMAB Catalyst Date - 2025-07-02 Drug - Givastomig (Claudin XXXX x 4-1BB bispecific antibody) Treatment - Claudin 18.2-positive metastatic gastric cancers" @Biopharma_Watch on X 2025-07-01 15:45:03 UTC XXX followers, XXX engagements
"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $PMN - 744.5K - 20.4M - XXXXX $PHGE - 1.8M - 46.7M - XXXXX $RANI - 2.0M - 50.4M - 25.22" @Biopharma_Watch on X 2025-07-14 15:45:03 UTC XXX followers, XXX engagements
"Highest Volume Ticker - Price - Volume $PTPI - 0.07$ - 266.5M $OCEA - 0.02$ - 171.4M $NCNA - 0.05$ - 128.8M $ME - 0.61$ - 29.7M $CUTR - 0.10$ - 29.5M" @Biopharma_Watch on X 2025-07-11 15:45:04 UTC XXX followers, XXX engagements
"$INMB Catalyst Date - 2025-07-27 Drug - XPro (selective soluble TNF inhibitor) Treatment - early Alzheimers Disease (AD) with biomarkers of inflammation" @Biopharma_Watch on X 2025-07-21 15:45:11 UTC XXX followers, XXX engagements
"Top Market Movers: Negative News Full Access: $TLX 14.47$ -XXXXX% July XX 2025 Telix Reports $204M Revenue Up XX% YOY" @Biopharma_Watch on X 2025-07-23 15:45:03 UTC XXX followers, XXX engagements
"$PHGE 0.40$ -XXXX% July XX 2025 BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis" @Biopharma_Watch on X 2025-07-15 15:45:08 UTC XXX followers, XXX engagements
"$GMED 53.30$ XXXX% July XX 2025 Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results" @Biopharma_Watch on X 2025-07-22 15:45:12 UTC XXX followers, XXX engagements
"$REPL Catalyst Date - 2025-07-22 Drug - RP1 (vusolimogene oderparepvec) Treatment - advanced melanoma" @Biopharma_Watch on X 2025-07-16 15:45:04 UTC XXX followers, XXX engagements
"$REPL Catalyst Date - 2025-07-22 Drug - RP1 (vusolimogene oderparepvec) Treatment - advanced melanoma" @Biopharma_Watch on X 2025-07-15 15:45:08 UTC XXX followers, XXX engagements
"Highest Volume Ticker - Price - Volume $OCEA - 0.02$ - 171.4M $RNAZ - 0.58$ - 59.3M $ME - 0.61$ - 29.7M $CUTR - 0.10$ - 29.5M $WBA - 18.72$ - 28.8M" @Biopharma_Watch on X 2025-05-01 15:45:04 UTC XXX followers, XXX engagements
"Latest catalysts: $RYTM Catalyst Date - 2025-07-12 Drug - setmelanotide Treatment - acquired hypothalamic obesity" @Biopharma_Watch on X 2025-07-11 15:45:03 UTC XXX followers, XXX engagements
"$ONCY 1.18$ -XXXX% July XX 2025 Oncolytics Biotech Regains Compliance with Nasdaq Trading Rules" @Biopharma_Watch on X 2025-07-23 15:45:13 UTC XXX followers, XX engagements
"Latest catalysts: $REGN Catalyst Date - 2025-07-10 Drug - Linvoseltamab (BCMAxCD3) Treatment - Multiple Myeloma" @Biopharma_Watch on X 2025-07-09 15:45:03 UTC XXX followers, XXX engagements
"Latest catalysts: $KOD Catalyst Date - 2025-07-16 Drug - Tarcocimab Treatment - Diabetic Retinopathy Wet AMD" @Biopharma_Watch on X 2025-07-15 15:45:04 UTC XXX followers, XXX engagements
"Top Market Movers: Positive News Full Access: $CGTX 0.75$ XXXX% July XX 2025 Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesines Protection of Neurons and Synapses in Alzheimers Disease" @Biopharma_Watch on X 2025-07-22 15:45:02 UTC XXX followers, XXX engagements
"$BCTX 0.83$ XXXX% July XX 2025 BriaCell Adds Mayo Clinic to Phase X Study in Metastatic Breast Cancer" @Biopharma_Watch on X 2025-07-16 15:45:06 UTC XXX followers, XXX engagements
"$BRKR 35.80$ -XXXXX% July XX 2025 Bruker Announces Second Quarter 2025 Preliminary Results Plans to Hold Q2 Earnings Conference Call on August X 2025" @Biopharma_Watch on X 2025-07-21 15:45:06 UTC XXX followers, XX engagements
"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $BRNS - 2.3M - 69.9M - XXXXX $QLGN - 1.6M - 48.1M - XXXXX $APM - 6.6M - 196.4M - 29.70" @Biopharma_Watch on X 2025-07-17 15:45:09 UTC XXX followers, XXX engagements
"Top Market Movers: Negative News Full Access: $EVO 3.66$ -XXXXX% July XX 2025 Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance" @Biopharma_Watch on X 2025-07-21 15:45:03 UTC XXX followers, XXX engagements
"$ALKS 26.50$ -XXXX% July XX 2025 Alkermes Announces Positive Topline Results From Vibrance-1 Phase X Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1" @Biopharma_Watch on X 2025-07-21 15:45:09 UTC XXX followers, XXX engagements
"$ONCY 1.18$ -XXXX% July XX 2025 Oncolytics Biotech Regains Compliance with Nasdaq Trading Rules" @Biopharma_Watch on X 2025-07-23 15:45:09 UTC XXX followers, XX engagements
"$CRNX Catalyst Date - 2025-07-13 Drug - PALSONIFY (paltusotine) Treatment - Acromegaly" @Biopharma_Watch on X 2025-07-11 15:45:09 UTC XXX followers, XXX engagements
"Latest catalysts: $REPL Catalyst Date - 2025-07-22 Drug - RP1 (vusolimogene oderparepvec) Treatment - advanced melanoma" @Biopharma_Watch on X 2025-07-21 15:45:03 UTC XXX followers, XXX engagements
"$REPL Catalyst Date - 2025-07-22 Drug - RP1 (vusolimogene oderparepvec) Treatment - advanced melanoma" @Biopharma_Watch on X 2025-07-17 15:45:09 UTC XXX followers, XXX engagements
"$IDYA 23.27$ XXXX% July XX 2025 IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849) a Potential First-in-Class DLL3-TOP1 ADC" @Biopharma_Watch on X 2025-07-23 15:45:08 UTC XXX followers, XX engagements
"Highest Volume Ticker - Price - Volume $KTTA - 1.92$ - 196.1M $OCEA - 0.02$ - 171.4M $ME - 0.61$ - 29.7M $CUTR - 0.10$ - 29.5M $WBA - 18.72$ - 28.8M" @Biopharma_Watch on X 2025-05-06 15:45:03 UTC XXX followers, XXX engagements
"Highest Volume Ticker - Price - Volume $BJDX - 7.90$ - 45.5M $PFE - 22.46$ - 40.1M $STSS - 0.02$ - 39.2M $ME - 0.61$ - 29.7M $CUTR - 0.10$ - 29.5M" @Biopharma_Watch on X 2025-04-07 16:00:07 UTC XXX followers, XXX engagements
"Highest Volume Ticker - Price - Volume $LXRX - 0.62$ - 248.2M $SNSE - 0.56$ - 129.1M $STSS - 0.04$ - 106.1M $CUTR - 0.10$ - 29.5M $WBA - 18.72$ - 28.8M" @Biopharma_Watch on X 2025-03-28 16:00:07 UTC XXX followers, XXX engagements
"Top Market Movers: Positive News Full Access: $ABVX 65.61$ XXXXXX% July XX 2025 Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 En" @Biopharma_Watch on X 2025-07-23 15:45:02 UTC XXX followers, XXX engagements
"$REPL Catalyst Date - 2025-07-22 Drug - RP1 (vusolimogene oderparepvec) Treatment - advanced melanoma" @Biopharma_Watch on X 2025-07-14 15:45:06 UTC XXX followers, XXX engagements